S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
S&P 500   3,006.72 (+0.69%)
DOW   26,827.64 (+0.21%)
QQQ   193.39 (+0.89%)
AAPL   240.51 (+1.73%)
FB   189.75 (+2.10%)
MSFT   138.39 (+0.71%)
GOOGL   1,244.23 (-0.01%)
AMZN   1,785.67 (+1.60%)
CGC   20.35 (+0.69%)
NVDA   196.11 (+2.95%)
MU   45.25 (+4.09%)
BABA   173.52 (+2.60%)
GE   8.79 (-1.90%)
TSLA   253.46 (-1.36%)
AMD   32.07 (+3.52%)
T   38.23 (-0.62%)
F   9.03 (-2.80%)
ACB   3.69 (+0.27%)
PRI   125.69 (+1.75%)
NFLX   278.05 (+1.00%)
BAC   31.02 (+2.21%)
GILD   65.22 (+0.48%)
DIS   130.26 (-0.48%)
Log in

Milestone Scientific Stock Price, News & Analysis (NYSEAMERICAN:MLSS)

$1.27
-0.08 (-5.93 %)
(As of 10/21/2019 04:00 PM ET)
Today's Range
$1.20
Now: $1.27
$1.38
50-Day Range N/A
52-Week Range
$0.26
Now: $1.27
$1.41
Volume984,109 shs
Average Volume287,398 shs
Market Capitalization$61.21 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:MLSS
CUSIPN/A
Phone+1-973-5352717

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees16
Market Cap$61.21 million
Next Earnings Date11/21/2019 (Estimated)
OptionableNot Optionable

Receive MLSS News and Ratings via Email

Sign-up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.


Milestone Scientific (NYSEAMERICAN:MLSS) Frequently Asked Questions

What is Milestone Scientific's stock symbol?

Milestone Scientific trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MLSS."

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) announced its earnings results on Wednesday, August, 14th. The medical instruments supplier reported ($0.02) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.02). The medical instruments supplier had revenue of $2.26 million for the quarter. View Milestone Scientific's Earnings History.

When is Milestone Scientific's next earnings date?

Milestone Scientific is scheduled to release their next quarterly earnings announcement on Thursday, November 21st 2019. View Earnings Estimates for Milestone Scientific.

What price target have analysts set for MLSS?

1 brokers have issued 12 month price objectives for Milestone Scientific's stock. Their forecasts range from $2.00 to $2.00. On average, they anticipate Milestone Scientific's stock price to reach $2.00 in the next year. This suggests a possible upside of 57.5% from the stock's current price. View Analyst Price Targets for Milestone Scientific.

What is the consensus analysts' recommendation for Milestone Scientific?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Scientific in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Milestone Scientific.

Has Milestone Scientific been receiving favorable news coverage?

News articles about MLSS stock have trended somewhat positive on Monday, according to InfoTrie. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Milestone Scientific earned a media sentiment score of 0.8 on InfoTrie's scale. They also assigned media coverage about the medical instruments supplier a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for Milestone Scientific.

Are investors shorting Milestone Scientific?

Milestone Scientific saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 307,700 shares, an increase of 49.8% from the August 30th total of 205,400 shares. Based on an average daily volume of 224,900 shares, the short-interest ratio is currently 1.4 days. Currently, 1.3% of the company's shares are sold short. View Milestone Scientific's Current Options Chain.

Who are some of Milestone Scientific's key competitors?

What other stocks do shareholders of Milestone Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Milestone Scientific investors own include Fortinet (FTNT), NovaBay Pharmaceuticals (NBY), Krystal Biotech (KRYS), Viper Energy Partners (VNOM), Knowles (KN), Osisko gold royalties (OR), CVS Health (CVS), Biocept (BIOC), Bellicum Pharmaceuticals (BLCM) and Cellectar Biosciences (CLRB).

Who are Milestone Scientific's key executives?

Milestone Scientific's management team includes the folowing people:
  • Mr. Leonard A. Osser, Founder, Interim CEO & Director (Age 72)
  • Mr. Joseph D'Agostino CPA, CPA, CFO & COO (Age 67)
  • Ms. Sharon Smith, Exec. VP of Global Sales & Marketing
  • Mr. Gian Domenico Trombetta, Pres & CEO of Wand Dental Inc. and Director (Age 58)
  • Mr. James McAvinn, Sr. VP of Sales & Marketing

How do I buy shares of Milestone Scientific?

Shares of MLSS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Milestone Scientific's stock price today?

One share of MLSS stock can currently be purchased for approximately $1.27.

How big of a company is Milestone Scientific?

Milestone Scientific has a market capitalization of $61.21 million. Milestone Scientific employs 16 workers across the globe.View Additional Information About Milestone Scientific.

What is Milestone Scientific's official website?

The official website for Milestone Scientific is http://www.milesci.com/.

How can I contact Milestone Scientific?

Milestone Scientific's mailing address is 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States. The medical instruments supplier can be reached via phone at +1-973-5352717.


MarketBeat Community Rating for Milestone Scientific (NYSEAMERICAN MLSS)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  89 (Vote Outperform)
Underperform Votes:  89 (Vote Underperform)
Total Votes:  178
MarketBeat's community ratings are surveys of what our community members think about Milestone Scientific and other stocks. Vote "Outperform" if you believe MLSS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MLSS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/21/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel